Home » Topics » Regulatory » Patents

Patents
RSS

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

FO-2546F: ACAT inhibitor from Albophoma yamanashiensis

May 17, 1996

SmithKline Beecham claims hemoregulatory agents

May 17, 1996

Mitsui Toatsu claims antitumor trifluorothymidine derivatives

May 17, 1996

Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists

May 17, 1996

Platinum complexes claimed by Nippon Kayaku

May 17, 1996

Novel antiarthritics claimed by Procter & Gamble

May 17, 1996

British Biotech reveals metalloproteinase inhibitors

May 17, 1996

COX-2 inhibitors claimed by Searle

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...